223 related articles for article (PubMed ID: 17106715)
1. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer.
Oba K; Teramukai S; Kobayashi M; Matsui T; Kodera Y; Sakamoto J
Cancer Immunol Immunother; 2007 Jun; 56(6):905-11. PubMed ID: 17106715
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials.
Oba MS; Teramukai S; Ohashi Y; Ogawa K; Maehara Y; Sakamoto J
Gastric Cancer; 2016 Apr; 19(2):616-624. PubMed ID: 25804300
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials.
Sakamoto J; Teramukai S; Nakazato H; Sato Y; Uchino J; Taguchi T; Ryoma Y; Ohashi Y
J Immunother; 2002; 25(5):405-12. PubMed ID: 12218778
[TBL] [Abstract][Full Text] [Related]
4. Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.
Tanaka H; Muguruma K; Ohira M; Kubo N; Yamashita Y; Maeda K; Sawada T; Hirakawa K
Anticancer Res; 2012 Aug; 32(8):3427-33. PubMed ID: 22843926
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled study of immunochemotherapy with OK-432 after curative surgery for gastric cancer.
Sato Y; Kondo M; Kohashi S; Takahashi N; Takahashi S; Sinohara T; Ono K; Matsuda M; Ryoma Y; Shiroto H; Kondo Y; Uchino J; Saito K; Todo S
J Immunother; 2004; 27(5):394-7. PubMed ID: 15314548
[TBL] [Abstract][Full Text] [Related]
6. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
[TBL] [Abstract][Full Text] [Related]
7. Postoperative PSK and OK-432 immunochemotherapy for patients with gastric cancer.
Maehara Y; Inutsuka S; Takeuchi H; Baba H; Kusumoto H; Sugimachi K
Cancer Chemother Pharmacol; 1993; 33(2):171-5. PubMed ID: 8261578
[TBL] [Abstract][Full Text] [Related]
8. [[Cooperative study on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer (II). Cooperative study group on surgical adjuvant immunochemotherapy for prevention of postoperative recurrence of gastric cancer supported by the Ministry of Health and Welfare (Kondo's group])].
Imaizumi M; Kondo T; Kamei H; Ichihashi H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2397-403. PubMed ID: 2124433
[TBL] [Abstract][Full Text] [Related]
9. Clinical potential of biological response modifiers combined with chemotherapy for gastric cancer. Japanese experience.
Shibata M; Nezu T; Fujisaki S; Andou K; Tomita R; Fukuzawa M
Dig Surg; 2002; 19(4):255-60. PubMed ID: 12207066
[TBL] [Abstract][Full Text] [Related]
10. Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy.
Hattori T; Nakajima T; Nakazato H; Tanabe T; Kikuchi K; Abe O; Kondo T; Taguchi T; Komi N; Sugimachi K
Jpn J Surg; 1990 Mar; 20(2):127-36. PubMed ID: 2111414
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy of gastric cancer: the Japanese experience.
Fukushima M
Semin Oncol; 1996 Jun; 23(3):369-78. PubMed ID: 8658221
[TBL] [Abstract][Full Text] [Related]
12. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer.
Tsujitani S; Kakeji Y; Orita H; Watanabe A; Kohnoe S; Baba H; Anai H; Maehara Y; Sugimachi K
Anticancer Res; 1992; 12(3):645-8. PubMed ID: 1622120
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of adjuvant immunochemotherapy in advanced gastric cancer].
Sakamoto J; Nakazato H
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2525-30. PubMed ID: 8279851
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer.
Sakamoto J; Teramukai S; Watanabe Y; Hayata Y; Okayasu T; Nakazato H; Ohashi Y;
J Immunother; 2001; 24(3):250-6. PubMed ID: 11394503
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials.
Sakamoto J; Morita S; Oba K; Matsui T; Kobayashi M; Nakazato H; Ohashi Y;
Cancer Immunol Immunother; 2006 Apr; 55(4):404-11. PubMed ID: 16133112
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
17. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Ichihashi H; Kondo T; Nakazato H
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Nakazato H; Koike A; Saji S; Ogawa N; Sakamoto J
Lancet; 1994 May; 343(8906):1122-6. PubMed ID: 7910230
[TBL] [Abstract][Full Text] [Related]
19. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer.
Popiela T; Kulig J; Czupryna A; Szczepanik AM; Zembala M
Gastric Cancer; 2004; 7(4):240-5. PubMed ID: 15616772
[TBL] [Abstract][Full Text] [Related]
20. [Randomized controlled study on adjuvant immunochemotherapy with carmofur (HCFU) for noncuratively resected and unresected gastric cancer].
Osawa S; Shiroto H; Kondo Y; Nakanishi Y; Fujisawa J; Miyakawa K; Oku T; Nishimura A; Uchino J
Gan To Kagaku Ryoho; 1996 Feb; 23(3):327-31. PubMed ID: 8712826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
